High-level levofloxacin-resistant emm12 group A Streptococcus, 2012-2018: A multicenter study in Taiwan
J Microbiol Immunol Infect. 2023 May 6:S1684-1182(23)00088-9. doi: 10.1016/j.jmii.2023.04.010. Online ahead of print.ABSTRACTHigh-level levofloxacin-resistant group A Streptococcus emerged in Taiwan in 2012. Among the 24 isolates identified, 23 belonged to emm12/ST36, most harbored the same GyrA and ParC mutations and were highly clonal. wgMLST showed them to be closely related to the Hong Kong scarlet fever outbreak strains. Continuous surveillance is warranted.PMID:37188572 | DOI:10.1016/j.jmii.2023.04.010
Source: Journal of Microbiology, Immunology, and Infection - Category: Microbiology Authors: Ying-Chi Huang Jui-Fen Lai Chi-Jung Wu I-Wen Huang Shu-Chen Kuo Ching-Len Liao Tzu-Wen Huang Tsai-Ling Lauderdale Source Type: research
More News: Allergy & Immunology | Group A Streptococcus | Hong Kong Health | Levaquin | Microbiology | Outbreaks | Study | Taiwan Health